Clinical Trial Update: Treprostinil Iontophoresis : a Pharmacodynamic and Pharmacokinetic Study [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update describing a pharmacodynamic and pharmacokinetic study of treprostinil administered by iontophoresis in systemic sclerosis (scleroderma) p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• Treprostinil (treprostinil)

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Scleroderma, Systemic | Phase 1, Phase 2 | Status: UNKNOWN